Scientists Create Mice With Human Brain Tissue: A Breakthrough in Neuroscience
In a remarkable scientific achievement that pushes the boundaries of what we thought possible, researchers have successfully created mice with an extraordinary amount of human brain tissue growing within their skulls. By genetically engineering these animals to lack significant portions of their own brains, scientists have developed a living laboratory where pea-sized clusters of human neurons can flourish, expand, and integrate into a developing nervous system. This groundbreaking work, published in the prestigious journal Nature, represents a new frontier in our ability to study the human brain and the devastating diseases that can affect it. The human tissue ultimately came to dominate the mouse cortex, the brain’s outer layer, creating a unique hybrid model that offers unprecedented insights into human neural circuits and brain disorders.
The journey to this breakthrough began in the early 2010s when researchers first discovered that stem cells could organize themselves into three-dimensional structures resembling aspects of the developing human brain. These miniature brain structures, called organoids, held tremendous promise but had significant limitations – they lacked the connections and sensory inputs that only a living, functioning brain can provide. In 2022, neuroscientist Sergiu Pașca and his team at Stanford University developed a method to transplant human organoids into newborn rats, achieving integration of human cells into about one-third of one side of the rat’s cortex. However, a fundamental problem remained: rat neurons mature much faster than human neurons, which limited how much the human tissue could develop and mature within this rodent host. This timing mismatch meant that the human brain cells couldn’t reach their full developmental potential in the rat model.
To overcome this obstacle, Pașca and his colleagues took a bold approach – they bred mice that were genetically engineered to develop without most of their cortex and the neighboring hippocampus, two critical brain structures involved in movement, learning, and memory that together account for roughly half of the brain’s total volume. While these mice showed some behavioral defects, they were surprisingly functional, able to move, eat, and interact with their environment despite their significant neurological differences. The empty space created by the missing tissue provided a perfect environment for human brain organoids to grow. When the researchers transplanted organoids grown from healthy donor stem cells into these mice, the procedure was remarkably successful, with the transplanted tissue taking hold in 25 out of 29 attempts – an extraordinary success rate that speaks to the careful design of the experiment.
What happened over the next three months was nothing short of remarkable. The human tissue expanded nearly fivefold in volume, ultimately filling more than 90 percent of the cortex. The tissue developed into a wide range of cell types, including rare neurons that have proven nearly impossible to generate in laboratory dishes. While the tissue lacked some features of a mature cortex, including its characteristic layered structure, it still formed extensive connections with the mouse nervous system, wiring itself into the brain’s existing circuitry in ways that could be studied and manipulated. This integration provides an unprecedented platform for studying how human neural circuits function and, crucially, how they malfunction in disease states.
The researchers immediately put their new model to work by studying cerebral palsy, a disability caused by damage to the developing brain. They subjected the grafted animals to oxygen deprivation, which is one of the known causes of cerebral palsy in humans. Afterward, the human tissue showed clear cellular signs of injury, and the mice developed problems with gait and limb coordination – features that mirror the disability in people. This demonstration opens up exciting possibilities for testing potential therapeutics for cerebral palsy and other neurological conditions. Pașca plans to use the mice to study frontotemporal dementia and genetic forms of autism, using organoids made from patient-derived cells affected by these conditions. This approach could revolutionize how we test treatments for neurological diseases, providing a more accurate model of human brain disorders than traditional animal models.
The technique has been described as “bold” by experts in the field, including H. Isaac Chen, a neurosurgeon at the University of Pennsylvania who studies brain organoids but was not involved in this research. The extent of humanization in these mice raises important ethical questions about where to draw the line in such experiments. However, Pașca has gone to unusual lengths to address these concerns, consulting an outside panel of experts led by Insoo Hyun, a bioethicist at the National University of Singapore. Hyun acknowledges that this new mouse model raises legitimate questions about ethical boundaries but notes that there is little evidence that these mice have crossed them. What matters, he argues, is not how much human tissue an animal contains, but what that tissue enables it to do. On tests of fine motor control and memory, the grafted mice’s performances fell between that of mice with intact brains and those lacking a cortex entirely – suggesting they haven’t gained any extraordinary cognitive abilities. For anyone concerned about genetically enhanced rodents plotting world domination, there’s little evidence of that here – these mice, despite their mostly human-derived cortex, remain far more Pinky than Brain.
